BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/19/2025 9:27:33 AM | Browse: 18 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 113647
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Allyl isothiocyanate ameliorates metabolic dysfunction-associated steatotic liver disease via vitamin D receptors in hepatocytes
Manuscript Source Unsolicited Manuscript
All Author List Ting Gao, Kang-Peng Zhong, Jun-Zhuo Wang, Yi Chen and Chun-Xiao Li
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Zhejiang Province No. LQ22H030001
Natural Science Foundation of Ningbo No. 2024J474
Ningbo Top Medical and Health Research Program No. 2023020612
Project of Ningbo Leading Medical and Healthy Discipline No. 2022-S04
Corresponding Author Chun-Xiao Li, PhD, Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, No. 59 Liuting Street, Haishu District, Ningbo 315010, Zhejiang Province, China. 11418130@zju.edu.cn
Key Words Allyl isothiocyanate; Metabolic dysfunction-associated steatotic liver disease; Vitamin D receptor; Fatty acid β-oxidation; Lipid synthesis
Core Tip Metabolic dysfunction-associated steatotic liver disease (MASLD) denotes a continuum of disorders unified by hepatic steatosis and can affect approximately one quarter of the global population, reaching up to 75% among individuals with obesity. This work seeks to define the functional contribution and mechanism of allyl isothiocyanate (AITC) in mitigating MASLD via the vitamin D receptor (VDR). In an in vitro MASLD model, AITC activates VDR through hepatocyte nuclear factor 4 alpha/microsomal triglyceride transfer protein/apolipoprotein B signaling, thereby reducing lipid accumulation and insulin resistance while promoting fatty acid β-oxidation. Taken together, these results show the therapeutic promise of AITC in MASLD.
Citation Gao T, Zhong KP, Wang JZ, Chen Y, Li CX. Allyl isothiocyanate ameliorates metabolic dysfunction-associated steatotic liver disease via vitamin D receptors in hepatocytes. World J Gastroenterol 2025; In press
Received
2025-09-01 08:55
Peer-Review Started
2025-09-01 08:57
To Make the First Decision
Return for Revision
2025-10-11 06:53
Revised
2025-10-24 06:21
Second Decision
2025-11-19 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-11-19 09:27
Articles in Press
2025-11-19 09:27
Publication Fee Transferred
2025-10-27 13:07
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com